UBS Group’s Vivani Medical VANI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $338K | Buy |
337,749
+331,035
| +4,931% | +$414K | ﹤0.01% | 6346 |
|
|
2025
Q4 | $8.26K | Sell |
6,714
-794
| -11% | -$1.15K | ﹤0.01% | 8379 |
|
|
2025
Q3 | $10.6K | Sell |
7,508
-4,360
| -37% | -$5.91K | ﹤0.01% | 8531 |
|
|
2025
Q2 | $15.3K | Buy |
11,868
+3,922
| +49% | +$4.32K | ﹤0.01% | 8621 |
|
|
2025
Q1 | $8.34K | Sell |
7,946
-10,872
| -58% | -$12.5K | ﹤0.01% | 8766 |
|
|
2024
Q4 | $21.8K | Buy |
18,818
+18,813
| +376,260% | +$23.8K | ﹤0.01% | 7813 |
|
|
2024
Q3 | $6 | Sell |
5
-47,156
| -100% | -$59K | ﹤0.01% | 9379 |
|
|
2024
Q2 | $59.4K | Buy |
47,161
+36,579
| +346% | +$62.7K | ﹤0.01% | 6553 |
|
|
2024
Q1 | $19.6K | Buy |
10,582
+9,411
| +804% | +$13.9K | ﹤0.01% | 6936 |
|
|
2023
Q4 | $1.19K | Sell |
1,171
-11,105
| -90% | -$11K | ﹤0.01% | 8379 |
|
|
2023
Q3 | $12.5K | Buy |
12,276
+12,167
| +11,162% | +$13.4K | ﹤0.01% | 7017 |
|
|
2023
Q2 | $132 | Buy |
109
+104
| +2,080% | +$128 | ﹤0.01% | 8465 |
|
|
2023
Q1 | $5 | Sell |
5
-3,034
| -100% | -$3.37K | ﹤0.01% | 9493 |
|
|
2022
Q4 | $2.58K | Buy |
3,039
+3,014
| +12,056% | +$4.91K | ﹤0.01% | 9655 |
|
|
2022
Q3 | $0 | Sell |
25
-1,761
| -99% | -$8.35K | ﹤0.01% | 10965 |
|
|
2022
Q2 | $11K | Buy |
1,786
+1,760
| +6,769% | +$9.49K | ﹤0.01% | 7854 |
|
|
2022
Q1 | $0 | Sell |
26
-1,025
| -98% | -$4.31K | ﹤0.01% | 10946 |
|
|
2021
Q4 | $5K | Buy |
1,051
+1,025
| +3,942% | +$7.49K | ﹤0.01% | 9422 |
|
|
2021
Q3 | $0 | Hold |
26
| – | – | ﹤0.01% | 10120 |
|
|
2021
Q2 | $0 | Sell |
26
-759
| -97% | -$14.7K | ﹤0.01% | 9849 |
|
|
2021
Q1 | $20K | Buy |
785
+759
| +2,919% | +$11.3K | ﹤0.01% | 7392 |
|
|
2020
Q4 | $0 | Sell |
26
-29,909
| -100% | -$106K | ﹤0.01% | 8789 |
|
|
2020
Q3 | $77K | Buy |
29,935
+29,095
| +3,464% | +$76.1K | ﹤0.01% | 5337 |
|
|
2020
Q2 | $2K | Buy |
840
+814
| +3,131% | +$2.89K | ﹤0.01% | 7661 |
|
|
2020
Q1 | $0 | Sell |
26
-76
| -75% | -$1K | ﹤0.01% | 8448 |
|
|
2019
Q4 | $14K | Buy |
102
+85
| +500% | +$1.67K | ﹤0.01% | 7102 |
|
|
2019
Q3 | $0 | Sell |
17
-336
| -95% | -$6.63K | ﹤0.01% | 8275 |
|
|
2019
Q2 | $6K | Sell |
353
-541
| -61% | -$11.1K | ﹤0.01% | 7328 |
|
|
2019
Q1 | $18K | Buy |
894
+466
| +109% | +$9.08K | ﹤0.01% | 6398 |
|
|
2018
Q4 | $9K | Buy |
428
+396
| +1,238% | +$12.6K | ﹤0.01% | 7293 |
|
|
2018
Q3 | $1K | Sell |
32
-464
| -94% | -$18.7K | ﹤0.01% | 7857 |
|
|
2018
Q2 | $20K | Sell |
496
-111
| -18% | -$4.83K | ﹤0.01% | 6701 |
|
|
2018
Q1 | $28K | Buy |
607
+152
| +33% | +$6.76K | ﹤0.01% | 6158 |
|
|
2017
Q4 | $21K | Sell |
455
-4,360
| -91% | -$145K | ﹤0.01% | 6525 |
|
|
2017
Q3 | $138K | Buy |
4,815
+3,868
| +408% | +$108K | ﹤0.01% | 5111 |
|
|
2017
Q2 | $28K | Buy |
947
+377
| +66% | +$10.7K | ﹤0.01% | 6063 |
|
|
2017
Q1 | $17K | Sell |
570
-60
| -10% | -$2.3K | ﹤0.01% | 6274 |
|
|
2016
Q4 | $30K | Buy |
630
+332
| +111% | +$19K | ﹤0.01% | 6236 |
|
|
2016
Q3 | $25K | Sell |
298
-428
| -59% | -$37.9K | ﹤0.01% | 6106 |
|
|
2016
Q2 | $62K | Buy |
726
+429
| +144% | +$44.6K | ﹤0.01% | 5362 |
|
|
2016
Q1 | $34K | Sell |
297
-324
| -52% | -$37.3K | ﹤0.01% | 5789 |
|
|
2015
Q4 | $88K | Buy |
621
+521
| +521% | +$76.3K | ﹤0.01% | 5317 |
|
|
2015
Q3 | $14K | Sell |
100
-9
| -8% | -$2.5K | ﹤0.01% | 7028 |
|
|
2015
Q2 | $36K | Sell |
109
-6
| -5% | -$1.92K | ﹤0.01% | 6309 |
|
|
2015
Q1 | $36K | Buy |
115
+59
| +105% | +$16.4K | ﹤0.01% | 6355 |
|
|
2014
Q4 | $14K | Buy |
+56
| New | +$19.5K | ﹤0.01% | 8093 |
|
Other funds holding VANI
VCM
TWM
VFT
MMG
UBS Group's VANI Position: Q1 2026 in Review
UBS Group increased its Vivani Medical (VANI) stake by 4,931% in Q1 2026, buying an estimated $414K and bringing the position to 337,749 shares worth $338K. The position accounts for ﹤0.01% of the portfolio, ranked #6346.
UBS Group first reported a position in VANI in Q4 2014 and has held it in 46 quarters since. 43 funds tracked by Wall St. Rank hold VANI as of Q1 2026.
- UBS Group held 337,749 shares of Vivani Medical worth $338K as of Q1 2026.
- UBS Group bought 331,035 Vivani Medical shares in Q1 2026, an estimated $414K.
- Vivani Medical made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #6346 holding.
- UBS Group first reported a position in Vivani Medical in Q4 2014 and has held it in 46 quarters since.
- 43 funds tracked by Wall St. Rank held Vivani Medical as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.